Guardant Health Inc. News

Latest updates and market news for GH

6 news

Jan 31 - Feb 6, 2026

Page 1

Merck Deepens Oncology And Vaccine Bets With Partnerships And Equity Stake

Simply Wall St.

3 days ago

Merck Deepens Oncology And Vaccine Bets With Partnerships And Equity Stake

Guardant Health to Participate in Upcoming Investor Conferences

Business Wire

3 days ago

Guardant Health to Participate in Upcoming Investor Conferences

📊

AI Sentiment

Positive

6/10

Merck Eyes Post Keytruda Growth With Eikon Stake And Guardant Pact

Simply Wall St.

4 days ago

Merck Eyes Post Keytruda Growth With Eikon Stake And Guardant Pact

Largest Published Study of Molecular Residual Disease (MRD) in Stage III Colon Cancer Shows Guardant Reveal Blood Test More Precisely Identifies Risk of Recurrence After Surgery to Support Timely Treatment Decisions

Business Wire

4 days ago

Largest Published Study of Molecular Residual Disease (MRD) in Stage III Colon Cancer Shows Guardant Reveal Blood Test More Precisely Identifies Risk of Recurrence After Surgery to Support Timely Treatment Decisions

📈

AI Sentiment

Highly Positive

9/10

3 Unpopular Stocks We Think Twice About

StockStory

5 days ago

3 Unpopular Stocks We Think Twice About

📉

AI Sentiment

Negative

3/10

Assessing Guardant Health (GH) Valuation After FDA Guardant360 CDx Approval And New Merck Collaboration

Simply Wall St.

7 days ago

Assessing Guardant Health (GH) Valuation After FDA Guardant360 CDx Approval And New Merck Collaboration

📈

AI Sentiment

Highly Positive

8/10

Share this news page

Share on Social Networks: